Siemens Healthineers joins race to supply coronavirus antibody tests [Reuters]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Reuters
Siemens Healthineers joins race to supply coronavirus antibody tests FRANKFURT (Reuters) - German diagnostics and medical imaging firm Siemens Healthineers will launch an antibody test to identify past coronavirus infections, competing with rivals Roche and Abbott. The Siemens division said in a statement on Thursday that the blood test, which requires the company’s processing equipment, would be available to large labs by late May 2020. More than 25 million tests could be supplied per month from June after an upgrade at a manufacturing site in Walpole, Massachusetts, it added. The test will “identify individuals infected with the virus who have developed an immune response to the virus, even if they were asymptomatic or never diagnosed with the disease”, Healthineers said. Governments across the world are looking to ease restrictions imposed to slow the spread of the virus. Knowing who has overcome an infection and may therefore have acquired immunity will be a key element of that ef
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Bank of America Co. from $125.00 to $115.00.MarketBeat
- Abbott Hosts Conference Call for First-Quarter EarningsPR Newswire
- FDA sketches out plan to bolster fragile US infant formula supply management [CBS News]CBS News
- FDA sketches out plan to bolster fragile US infant formula supply management [CNN]CNN
- Abbott Laboratories (NYSE: ABT) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.MarketBeat
ABT
Earnings
- 1/25/23 - Beat
ABT
Sec Filings
- 3/17/23 - Form ARS
- 3/17/23 - Form DEFA14A
- 3/17/23 - Form DEF
- ABT's page on the SEC website